BIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9, 2023
Get Alerts BIOL Hot Sheet
Join SI Premium – FREE
To access the live call, dial 866-682-6100 (
A live and archived webcast of the conference call will be accessible on the BIOLASE Investor Relations Page. In addition, a phone replay will be available approximately two hours following the end of the call, and it will remain available for one week. To access the call replay, dial 877-481-4010 or +1 919-882-2331 (International) and enter replay passcode 49456.
About BIOLASE
BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. As of
For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.
Contacts:
EVC Group, Inc.
(732) 232-6914
[email protected]; [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-to-report-third-quarter-2023-results-on-november-9-2023-301980592.html
SOURCE BIOLASE, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Origin Energy and Landis+Gyr bring large-scale smart gas technology to Australian homes and businesses
- Papa Murphy's Launches "Summer Selects" Pizza Deals to Make Summer Meals Easy, Delicious and Budget-Friendly
- Keycafe Expands Executive Leadership with Appointments of Rudi Airisto and Robert Johnston as Company Enters Next Phase of Global Growth
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share